Pfizer inks marketing deal for colorectal cancer test; Zai Lab douses a hot rumor about a Hong Kong IPO
→ Pfizer has inked a deal with Madison, WI-based Exact Sciences to help promote a DNA screening test for colorectal cancer. The agreement, which extends …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
